Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.
about
Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysisAntibody-based imaging of HER-2: moving into the clinic.Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging.Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging AgentMR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals.Chemically modified antibodies as diagnostic imaging agentsImproved speciation characteristics of PEGylated indocyanine green-labeled Panitumumab: revisiting the solution and spectroscopic properties of a near-infrared emitting anti-HER1 antibody for optical imaging of cancer.Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.Multiplexed imaging in cancer diagnosis: applications and future advances.Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signalsTargeting and Imaging of Cancer Cells via Monosaccharide-Imprinted Fluorescent NanoparticlesPerformance characteristics of a positron projection imager for mouse whole-body imaging.Molecular imaging probes for diagnosis and therapy evaluation of breast cancerIntraoperative imaging in ovarian cancer: fact or fiction?Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents.Optical probes and the applications in multimodality imaging.Optical and opto-acoustic interventional imaging.A molecular imaging primer: modalities, imaging agents, and applications.Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.In vivo imaging with antibodies and engineered fragments.Monoclonal antibody-based optical molecular imaging probes; considerations and caveats in chemistry, biology and pharmacology.Deglycosylation of mAb by EndoS for improved molecular imaging.Imaging of anticancer drug action in single cells.Next-generation imaging development for nanoparticle biodistribution measurements.Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptideDerivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations.Fluorescence-Guided Surgery.Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI.Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations.
P2860
Q27027682-A60170EC-A157-448B-8E06-40B871440381Q30423880-96BE5E17-E6BF-4492-B9D6-FB2D1FD1C28DQ30472127-407744F6-834A-4E07-BC23-C915C684382FQ33661325-80F515D1-0E4A-4730-A2EA-8388A5FEF6E2Q34111208-E18BF267-63D4-4437-AD9E-C83913652084Q34204259-91248095-09BD-4F38-80EF-D3E2E2CC12A2Q34441433-2BAB837B-6D74-4436-8F6F-01964A4C49FAQ34785833-989D3744-C35A-4F84-B34B-D071C845D9D7Q35600809-8521CDB7-66FE-45A0-BEE5-266146C1668EQ35909379-70B3659D-B66C-4CA7-8BF4-E26E1C0D01ECQ36105964-1E17DD03-B066-4EDD-8BA5-DE458D1BEF59Q36143279-F11E9AEA-1F9F-437F-90DF-ECA5FFF0CF4DQ36158324-8BDC5BC4-DC76-4453-BD62-04121E1E09B1Q36657226-78335A24-8E34-4D26-BB3F-A4638680CC08Q36681074-CB834208-F0CB-4369-8EEE-710F9D0B7198Q36692448-4F1DB3FB-6F28-4CCC-9934-E1BE71616592Q37149571-2558138B-3B4C-4252-83B7-2DD60994965FQ37633071-9427BC6B-0EC3-495D-9DC4-1E82B0407D0BQ37732381-DCDB56FA-1C1B-406A-9B4B-04F406B48DE7Q37827710-0C4D9433-6BEE-465B-A707-075EFE40F69EQ37829994-54CEC134-6614-45BC-B717-24DF374D0BEAQ37974089-4B7D6B5A-CCC5-4E01-BC50-7DCC730EF424Q38005672-5DF52273-D66B-4FBD-80BE-98854ADCBE3FQ38213539-8E593AC9-4DF6-4E49-8223-212DCC87F6BCQ38454458-24B6615C-0049-4072-AF5B-C538D884DD78Q38860216-7D1CE3DB-EB7C-43E0-BA40-24438BA3ABE4Q38964828-7041B235-CB79-4ADD-894F-AE85E86CAB2BQ39392711-7B7B0AE0-D8FB-49B4-B32E-C0C0CB0F3335Q39837631-A1CD076B-96D7-4287-9A90-1C8667A0BCE3Q42850578-F2CB3DEC-4B77-4354-B9E8-2C8F0C832D11Q47591838-C8FC6FD9-8A59-4B80-B536-2CC5D2D8804EQ49472946-E67F1510-D39A-468A-BBD1-1E6C5753B58FQ50623027-0A85738E-3020-46B2-86E0-F30E8C9A0F67Q52740018-091ABECE-AEB3-446D-9525-7B6D8B876047
P2860
Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dual-modality molecular imagin ...... ive targeted cancer detection.
@en
Dual-modality molecular imagin ...... ive targeted cancer detection.
@nl
type
label
Dual-modality molecular imagin ...... ive targeted cancer detection.
@en
Dual-modality molecular imagin ...... ive targeted cancer detection.
@nl
prefLabel
Dual-modality molecular imagin ...... ive targeted cancer detection.
@en
Dual-modality molecular imagin ...... ive targeted cancer detection.
@nl
P2093
P2860
P356
P1476
Dual-modality molecular imagin ...... ive targeted cancer detection.
@en
P2093
Celeste A S Regino
Hisataka Kobayashi
Jurgen Seidel
Mark Williams
Michael V Green
Mikako Ogawa
Nobuyuki Kosaka
Peter L Choyke
P2860
P304
P356
10.1021/BC900362K
P577
2009-11-01T00:00:00Z